In a recent study published in JAMA Oncology, researchers found that in a large group of patients with metastatic colorectal cancer, drinking a few cups of coffee a day was linked to longer survival and a lower risk of cancer worsening.
The findings are in line with earlier studies showing a connection between regular coffee drinking and improved outcomes in patients with non-metastatic colorectal cancer.
The research is Dana-Farber Cancer Institute and elsewhere. One author is Dana-Farber’s Chen Yuan, ScD.
In the study, the team examined 1,171 patients treated for metastatic colorectal cancer.
They found those who drank two to three cups of coffee a day were likely to live longer overall, and had a long time before their disease worsened than those who didn’t drink coffee.
Participants who drank larger amounts of coffee—more than four cups a day—had an even greater benefit in these measures. The benefits held for both caffeinated and decaffeinated coffee.
The team says it’s known that several compounds in coffee have antioxidant, anti-inflammatory, and other properties that may be active against cancer.
Previous studies have found that higher coffee intake was linked to improved survival in patients with stage 3 colon cancer.
Although it is premature to recommend a high intake of coffee as a potential treatment for colorectal cancer, the study suggests that drinking coffee is not harmful and may potentially be beneficial.
If you care about colon cancer, please read studies about colon cancer and stomach cancer could be both caused by this bug and findings of listen to your gut to prevent colon cancer.
For more information about colon cancer and your health, please see recent studies about this exercise may effectively reduce colon cancer growth and results showing that strawberry tree honey may stop colon cancer growth.
Copyright © 2021 Knowridge Science Report. All rights reserved.
